Question 1

What is Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index?

Accepted Answer

For more information about this series, see: NQUSL201030N (https://indexes.nasdaq.com/Index/Overview/NQUSL201030N)
Copyright © 2025, NASDAQ, Inc.

Question 2

Where does Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index data come from?

Accepted Answer

This dataset is sourced from FRED (FRED), a trusted provider of economic and financial data. DataSetIQ aggregates and standardizes this data for easy access and analysis.

Question 3

How often is Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index updated?

Accepted Answer

This dataset is updated on a d basis by FRED. DataSetIQ syncs the latest data regularly to ensure you have access to the most current information.

Question 4

What time period does Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index cover?

Accepted Answer

This dataset covers the period from 2012 to 2026. The temporal coverage allows for historical analysis and trend identification over 14 years of data.

Question 5

What units is Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index measured in?

Accepted Answer

The data in this dataset is measured in Index. Understanding the measurement units is important for accurate interpretation and comparison with other datasets.

Question 6

What is the data quality score for Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index?

Accepted Answer

Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index has a DataSetIQ score of 68/100. This score measures data quality based on completeness, timeliness, consistency, and coverage metrics.

Nasdaq US Large Cap Pharmaceuticals and Biotechnology Net Total Return Index

Data IQ Overview

About this dataset

Current Value

Dataset Ingestion in Progress

Dataset Update Available